753 related articles for article (PubMed ID: 11528572)
1. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
3. Pertussis after end of a mass vaccination project--end of the "vaccination honey-moon".
Trollfors B; Dotevall L; Sundh V; Welinder-Olsson C
Vaccine; 2011 Mar; 29(13):2444-50. PubMed ID: 21292010
[TBL] [Abstract][Full Text] [Related]
4. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
[TBL] [Abstract][Full Text] [Related]
5. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
6. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
Olin P
Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
[TBL] [Abstract][Full Text] [Related]
7. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
Liese JG; Stojanov S; Belohradsky BH
Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
[TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
[TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
11. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of acellular pertussis vaccine in young infants.
Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
[TBL] [Abstract][Full Text] [Related]
14. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
[No Abstract] [Full Text] [Related]
15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
16. The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP.
Robbins JB; Schneerson R; Keith JM; Shiloach J; Miller M; Trollors B
Vaccine; 2007 Apr; 25(15):2811-6. PubMed ID: 17291636
[TBL] [Abstract][Full Text] [Related]
17. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848
[TBL] [Abstract][Full Text] [Related]
19. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
[TBL] [Abstract][Full Text] [Related]
20. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
